294 related articles for article (PubMed ID: 21843852)
1. [Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study].
Wolters R; Wöckel A; Wischnewsky M; Kreienberg R
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):468-75. PubMed ID: 21843852
[TBL] [Abstract][Full Text] [Related]
2. Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study.
Schwentner L; Wolters R; Koretz K; Wischnewsky MB; Kreienberg R; Rottscholl R; Wöckel A
Breast Cancer Res Treat; 2012 Apr; 132(3):1073-80. PubMed ID: 22205141
[TBL] [Abstract][Full Text] [Related]
3. Impact of guideline conformity on breast cancer therapy: results of a 13-year retrospective cohort study.
Wöckel A; Varga D; Atassi Z; Kurzeder C; Wolters R; Wischnewsky M; Wulff C; Kreienberg R
Onkologie; 2010; 33(1-2):21-8. PubMed ID: 20164658
[TBL] [Abstract][Full Text] [Related]
4. Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients.
Schwentner L; Wolters R; Wischnewsky M; Kreienberg R; Wöckel A
Breast; 2012 Apr; 21(2):171-7. PubMed ID: 21945313
[TBL] [Abstract][Full Text] [Related]
5. Effects of guideline adherence in primary breast cancer--a 5-year multi-center cohort study of 3976 patients.
Wöckel A; Kurzeder C; Geyer V; Novasphenny I; Wolters R; Wischnewsky M; Kreienberg R; Varga D
Breast; 2010 Apr; 19(2):120-7. PubMed ID: 20117932
[TBL] [Abstract][Full Text] [Related]
6. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients.
Wolters R; Wöckel A; Janni W; Novopashenny I; Ebner F; Kreienberg R; Wischnewsky M; Schwentner L;
Breast Cancer Res Treat; 2013 Dec; 142(3):579-90. PubMed ID: 24258258
[TBL] [Abstract][Full Text] [Related]
7. Participation in adjuvant clinical breast cancer trials: does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9,433 patients.
Schwentner L; Van Ewijk R; Kurzeder C; Hoffmann I; König J; Kreienberg R; Blettner M; Wöckel A
Eur J Cancer; 2013 Feb; 49(3):553-63. PubMed ID: 22959469
[TBL] [Abstract][Full Text] [Related]
8. Adherence to quality indicators and survival in patients with breast cancer.
Cheng SH; Wang CJ; Lin JL; Horng CF; Lu MC; Asch SM; Hilborne LH; Liu MC; Chen CM; Huang AT
Med Care; 2009 Feb; 47(2):217-25. PubMed ID: 19169123
[TBL] [Abstract][Full Text] [Related]
9. Effects of quality of treatment on prognosis in primary breast cancer patients treated in daily practice.
Ottevanger PB; De Mulder PH; Grol RP; Van Lier H; Beex LV
Anticancer Res; 2002; 22(1A):459-65. PubMed ID: 12017333
[TBL] [Abstract][Full Text] [Related]
10. Does guideline-adherent therapy improve the outcome for early-onset breast cancer patients?
Varga D; Wischnewsky M; Atassi Z; Wolters R; Geyer V; Strunz K; Kreienberg R; Woeckel A
Oncology; 2010; 78(3-4):189-95. PubMed ID: 20414007
[TBL] [Abstract][Full Text] [Related]
11. Changes in survival after breast cancer: improvements in diagnosis or treatment?
Webb PM; Cummings MC; Bain CJ; Furnival CM
Breast; 2004 Feb; 13(1):7-14. PubMed ID: 14759710
[TBL] [Abstract][Full Text] [Related]
12. [Practice guideline for breast cancer rehabilitation from the perspective of the rehabilitation centres: findings of a user survey on acceptance and practicability of the pilot version].
Winnefeld M; Brüggemann S
Rehabilitation (Stuttg); 2008 Dec; 47(6):334-42. PubMed ID: 19085794
[TBL] [Abstract][Full Text] [Related]
13. Highly significant improvement in guideline adherence, relapse-free and overall survival in breast cancer patients when treated at certified breast cancer centres: An evaluation of 8323 patients.
Kreienberg R; Wöckel A; Wischnewsky M
Breast; 2018 Aug; 40():54-59. PubMed ID: 29698925
[TBL] [Abstract][Full Text] [Related]
14. Analysis of multidisciplinary lung cancer practice.
Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
[TBL] [Abstract][Full Text] [Related]
15. Negative margin status improves local control in conservatively managed breast cancer patients.
Obedian E; Haffty BG
Cancer J Sci Am; 2000; 6(1):28-33. PubMed ID: 10696736
[TBL] [Abstract][Full Text] [Related]
16. Trends in breast cancer treatment in Korea and impact of compliance with consensus recommendations on survival.
Yun YH; Park SM; Noh DY; Nam SJ; Ahn SH; Park BW; Lee ES
Breast Cancer Res Treat; 2007 Dec; 106(2):245-53. PubMed ID: 17972176
[TBL] [Abstract][Full Text] [Related]
17. [The German Guideline Clearinghouse on Breast Cancer: the need for frequent updating of breast cancer guidelines requires effective guideline updating procedures].
Weingart O; Sonntag D; Trapp H; Bartsch HH; Baumeister RG; Goerke K; Giersiepen K; Hindenburg HJ; Ming K; Schulz-Wendtland R; Störkel S; Kober T; Thole H; Kirchner H; Ollenschläger G;
Z Arztl Fortbild Qualitatssich; 2004 Aug; 98(5):403-11. PubMed ID: 15487388
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer.
Borgquist S; Jögi A; Pontén F; Rydén L; Brennan DJ; Jirström K
Breast Cancer Res; 2008; 10(5):R79. PubMed ID: 18808688
[TBL] [Abstract][Full Text] [Related]
19. Comparison of early onset breast cancer patients to older premenopausal breast cancer patients.
Varga D; Koenig J; Kuhr K; Strunz K; Geyer V; Kurzeder C; Atassi Z; Blettner M; Kreienberg R; Woeckel A
Arch Gynecol Obstet; 2010 Oct; 282(4):427-32. PubMed ID: 20047053
[TBL] [Abstract][Full Text] [Related]
20. Guidelines are advantageous, though not essential for improved survival among breast cancer patients.
Wolters R; Wischhusen J; Stüber T; Weiss CR; Krockberger M; Bartmann C; Blettner M; Janni W; Kreienberg R; Schwentner L; Novopashenny I; Wischnewsky M; Wöckel A; Diessner J
Breast Cancer Res Treat; 2015 Jul; 152(2):357-66. PubMed ID: 26105798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
